Drug Approval | June 17, 2025
Briefs: Hikal and Sun Pharma
Sun Pharma gets 8 observations from USFDA for Halol facility
Sun Pharma gets 8 observations from USFDA for Halol facility
25 women students to receive internship, training, and mentorship in Life Sciences segment
Launches FSSAI’s inclusive campaign to stop obesity with multilingual, sign language outreach and multi-platform media engagement under Eat Right India programme
The company has also launched its first three 24*7 pharmacy stores via COCO model in Bengaluru
Overall investment in the US facility is estimated around US$50 million
Notably, 36 female students have been placed in Production and Manufacturing roles, reflecting the growing representation of women in core biotech operations
Biocon Foundation has been steadfast in its mission to empower underserved communities through innovative healthcare solutions, education, and sustainable development initiatives
Cipla Limited has received final approval from the USFDA for the New Drug Application submitted for ‘Nilotinib Capsules 50, 150 and 200 mg’
_256_384.jpg)
Hikal Limited announces the completion of the US Food and Drug Administration (USFDA) inspection at its Jigani unit, Bengaluru
EBITDA grew 46.9% YoY to Rs. 210.3 crore with EBITDA margin at 18.2%, grew 401 bps YoY and the reported PAT at Rs. 90 crore
Subscribe To Our Newsletter & Stay Updated
